Travere Therapeutics, Inc.

TVTXNASDAQHealthcare● Active

$47.03

+$1.22(+2.67%)

Market Cap$4.4B

P/E Ratio—

52W High$48.61

52W Low$13.88

Avg Volume2.2M

Open$46.60

Beta1.14

Employees Ownership Insider Trades

Travere Therapeutics, Inc. (TVTX) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · TVTX · as of Feb 19, 2026

Latest filing snapshot

497

+112+29.09%vs prior year

Travere Therapeutics, Inc. (TVTX) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

497

Change (1Y)

+112

Growth % (1Y)

+29.09%

Revenue / Employee

$987.4K

Net Income / Employee

$-51.4K

Market Cap

$4.4B

TVTX Employee Count

2009 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-02-19	2025-12-31	497	+112	+29.09%
2025-02-21	2024-12-31	385	+5	+1.32%
2024-02-20	2023-12-31	380	-82	-17.75%
2023-02-23	2022-12-31	462	+152	+49.03%
2022-02-24	2021-12-31	310	+48	+18.32%
2021-03-01	2020-12-31	262	+41	+18.55%
2020-02-24	2019-12-31	221	+7	+3.27%
2019-02-26	2018-12-31	214	+41	+23.70%
2018-02-27	2017-12-31	173	+38	+28.15%
2017-03-01	2016-12-31	135	+5	+3.85%

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

AAPG

Ascentage Pharma Group International

567$1.6B #2

TVTX

Travere Therapeutics, Inc.YOU

497$4.4B #3

APGE

Apogee Therapeutics, Inc.

196$5.1B #4

CGON

CG Oncology, Inc. Common stock

Centessa Pharmaceuticals plc

77$6.1B

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · TVTX peer comparison

About TVTX employees

TVTX Employees · Headcount

Travere Therapeutics, Inc. (TVTX) employee data is sourced from the annual SEC 10-K filing. As of 2025, Travere Therapeutics, Inc. had 497 full-time employees globally. Full-time employees only. Global consolidated headcount.

Travere Therapeutics, Inc. employs 497 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $987,380, reflecting the company's operational efficiency.

Travere Therapeutics, Inc.'s workforce increased by 112 (29.09%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Travere Therapeutics, Inc.'s revenue per employee of $987,380 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

TVTX Employees · 5 questions

As of the latest SEC 10-K filing (2025), Travere Therapeutics, Inc. had 497 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Travere Therapeutics, Inc. employee counthow many employees does Travere Therapeutics, Inc. haveTVTX total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-02-19